(131)I-metaiodobenzylguanidine ((131)I-MIBG) therapy for residual neuroblastoma: a mono-institutional experience with 43 patients

Por Garaventa, A, Bellagamba, O, Piccolo, M S Lo, Milanaccio, C, Lanino, E, Bertolazzi, L, Villavecchia, G P, Cabria, M, Scopinaro, G, Claudiani, F, Bernardi, B De
Publicado em 1999

Detection of GD2-positive cells in bone marrow samples and survival of patients with localised neuroblastoma

Por Corrias, M V, Parodi, S, Haupt, R, Lacitignola, L, Negri, F, Sementa, A R, Dau, D, Scuderi, F, Carlini, B, Bianchi, M, Casale, F, Faulkner, L, Garaventa, A
Publicado em 2008

Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplifica...

Por Defferrari, R, Mazzocco, K, Ambros, I M, Ambros, P F, Bedwell, C, Beiske, K, Bénard, J, Berbegall, A P, Bown, N, Combaret, V, Couturier, J, Erminio, G, Gambini, C, Garaventa, A, Gross, N, Haupt, R, Kohler, J, Jeison, M, Lunec, J, Marques, B, Martinsson, T, Noguera, R, Parodi, S, Schleiermacher, G, Tweddle, D A, Valent, A, Van Roy, N, Vicha, A, Villamon, E, Tonini, G P
Publicado no Br J Cancer (2015)